8/22/2013

The European Commission has allocated $2 million for studies of antibodies that will eradicate tumors by destroying the tumor's blood vessels. Britain's University of Birmingham and a biotech company in Utrecht, the Netherlands, received the European Industrial Doctorate grant, which sponsors academic and business partnerships.

Related Summaries